BP15042
|
CP-105696
|
|
|
|
CP-105696 is a selective antagonist of Leukotriene B4 Receptor (IC50: 8.42 nM).
|
BP15043
|
TLR3-IN-1
|
|
|
|
CU CPT 4a is a selective TLR3 inhibitor (IC50: 3.44 μM in RAW 264.7 cells). It can inhibit TLR3/dsRNA complex-mediated downstream signaling pathways and inhibit the production of TNF-α and IL-1β in whole cells.
|
BP15044
|
CU-115
|
|
|
|
CU-115 is a selective antagonist of TLR8 with IC50s of 1.04 µM and >50 µM for TLR8 and TLR7, respectively.
|
BP15045
|
CU-CPT22
|
|
|
|
CU-CPT22 is the first probe for the complex between toll-like receptors TLR1 and TLR2. CU-CPT22 binds at the interface of TLR1 and TLR2 (IC50 = 0.58 μM). It competes with the synthetic triacylated lipoprotein (Pam3CSK4) binding to TLR1/2 (Ki: 0.41 μM).
|
BP15046
|
Curvularin
|
|
|
|
Curvulin, naturally isolated from Campylobacter curvulans, is a fungal metabolite and a potent mycotoxin that inhibits cytokine-induced nitric oxide synthase (iNOS) with IC50 of 9.5 μM.
|
BP15047
|
Cyclomorusin
|
|
|
|
Cyclomorusin exhibits competitive inhibition toward monophenolase activity of mushroom tyrosinase, the IC50 value of 0.092 microM. It evokes the stimulation of superoxide anion generation in fMLP-stimulated rat neutrophils. Cyclomorusin, neocyclomorusin and kuwanon C inhibited cholinesterase enzyme in a dose-dependent manner with K(i) values ranging between 3.1 and 37.5 uM and between 1.7 and 19.1 uM against acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) enzymes, respectively.
|
BP15048
|
Dactylorhin A
|
|
|
|
Dactylorhin A, a succinate derivative ester, is isolated from rhizomes of Gymnadenia conopsea. Dactylorhin A exhibits moderate inhibitory effect on NO production effects in RAW 264.7 macrophage cells.
|
BP15049
|
Dapansutrile
|
|
|
|
Dapansutrile is a potent, selective and orally active NLRP3 inflammasome inhibitor, with Anti-inflammatory and analgesic activity.
|
BP15050
|
Deacetylasperulosidic Acid
|
|
|
|
Deacetylasperulosidic acid is a natural compound of Morinda citrifolia fruit. It has antioxidant activity by increasing superoxide dismutase activity. It also prevents 4-nitroquinoline 1-oxide (4NQO) induced DNA damage in vitro, suppresses IL-2 production along with the activation of natural killer cells.
|
BP15051
|
Dehydroandrographolide
|
|
|
|
Dehydroandrographolide is a natural compound extracted from herbal medicine Andrographis paniculata (Burm f) Nees.
|
BP15052
|
Dehydrogeijerin
|
|
|
|
Dehydrogeijerin significantly inhibits the inflammatory activity of activated macrophages, suggesting that it could be a potential candidate for the treatment of inflammatory disease.
|
BP15053
|
Delphinidin-3-sambubioside chloride
|
|
|
|
Delphinidin-3-sambubioside chloride has antioxidant activity.
|
BP15054
|
Desmethyl Celecoxib
|
|
|
|
Demethyl celecoxib is a selective inhibitor of COX-2 with anti-inflammatory activity (IC50 of 32 nM). with anti-inflammatory activities. Desmethyl Celecoxib is an analog of Celecoxib and with the optimal yield of 75%.
|
BP15055
|
Dihydrotanshinone I
|
|
|
|
Dihydrotanshinone I is a natural compound extracted from Salvia miltiorrhiza Bunge used for treating of cardiovascular diseases.
|
BP15056
|
Di-O-methyldemethoxycurcumin
|
|
|
|
Di-O-methyldemethoxycurcumin is a Curcumin analog isolated from medicinal plant turmeric di-orthomethyldemethoxycurcumin, anti-inflammatory and antioxidant properties Inhibition of IL-6 production, EC50 is 16.20μg/mL.
|
BP15057
|
Diosmin
|
|
|
|
Diosmin is a bioflavonoid that strengthens vascular walls.
|
BP15058
|
DMNQ
|
|
|
|
DMNQ is a 1,4-naphthoquinone that acts as a redox-cycling agent, typically increasing intracellular superoxide and hydrogen peroxide formation.DMNQ increases ROS generation
|
BP15059
|
DW-1350
|
|
|
|
DW-1350 is an antagonist of LTB4 receptor.
|
BP15060
|
Ecabet Sodium
|
|
|
|
Ecabet sodium: a potential new agent in the management of distal colitis.
|
BP15061
|
Efaproxiral Sodium
|
|
|
|
Efaproxiral Sodium, a synthetic allosteric modifier of hemoglobin, is utilized for brain metastases originating from breast cancer.
|